Shri Ahimsa Naturals Ltd
Incorporated in 1990, Shri Ahimsa Naturals Limited extracts and manufactures Caffeine Anhydrous, Green Coffee Bean Extracts, and Crude Caffeine, also trading other herbal extracts.[1]
- Market Cap ₹ 377 Cr.
- Current Price ₹ 162
- High / Low ₹ 173 / 126
- Stock P/E 17.2
- Book Value ₹
- Dividend Yield 0.00 %
- ROCE 24.2 %
- ROE 18.4 %
- Face Value ₹ 10.0
Pros
- Company has reduced debt.
- Company is almost debt free.
- Company has delivered good profit growth of 78.9% CAGR over last 5 years
- Company has a good return on equity (ROE) track record: 3 Years ROE 33.0%
- Company's working capital requirements have reduced from 123 days to 92.7 days
Cons
- Promoter holding has decreased over last quarter: -25.6%
- Debtor days have increased from 62.9 to 96.2 days.
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
Half Yearly Results
Standalone Figures in Rs. Crores / View Consolidated
Profit & Loss
Standalone Figures in Rs. Crores / View Consolidated
| Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
|---|---|---|---|---|---|---|
| 22 | 28 | 58 | 104 | 78 | 96 | |
| 18 | 24 | 41 | 54 | 51 | 65 | |
| Operating Profit | 4 | 4 | 17 | 50 | 27 | 30 |
| OPM % | 17% | 15% | 30% | 48% | 34% | 32% |
| 1 | 0 | 1 | 2 | 1 | 2 | |
| Interest | 2 | 1 | 2 | 1 | 1 | 1 |
| Depreciation | 1 | 1 | 1 | 1 | 1 | 2 |
| Profit before tax | 2 | 2 | 16 | 51 | 25 | 30 |
| Tax % | 27% | 32% | 30% | 29% | 17% | 26% |
| 1 | 2 | 11 | 36 | 21 | 22 | |
| EPS in Rs | 3.44 | 3.37 | 21.53 | 68.21 | 11.44 | 9.42 |
| Dividend Payout % | 0% | 0% | 0% | 0% | 0% | 0% |
| Compounded Sales Growth | |
|---|---|
| 10 Years: | % |
| 5 Years: | 35% |
| 3 Years: | 18% |
| TTM: | 23% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | % |
| 5 Years: | 79% |
| 3 Years: | 25% |
| TTM: | 5% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | % |
| 1 Year: | % |
| Return on Equity | |
|---|---|
| 10 Years: | % |
| 5 Years: | 34% |
| 3 Years: | 33% |
| Last Year: | 18% |
Balance Sheet
Standalone Figures in Rs. Crores / View Consolidated
| Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
|---|---|---|---|---|---|---|
| Equity Capital | 3 | 5 | 5 | 5 | 18 | 23 |
| Reserves | 6 | 9 | 22 | 58 | 66 | 131 |
| 14 | 13 | 6 | 3 | 14 | 0 | |
| 4 | 4 | 7 | 8 | 5 | 38 | |
| Total Liabilities | 27 | 31 | 41 | 74 | 103 | 193 |
| 15 | 17 | 21 | 28 | 32 | 39 | |
| CWIP | 0 | 1 | 3 | 3 | 6 | 2 |
| Investments | 0 | 0 | 0 | 1 | 10 | 10 |
| 12 | 12 | 17 | 42 | 55 | 143 | |
| Total Assets | 27 | 31 | 41 | 74 | 103 | 193 |
Cash Flows
Standalone Figures in Rs. Crores / View Consolidated
| Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
|---|---|---|---|---|---|---|
| 6 | 3 | 14 | 20 | 6 | ||
| -1 | -4 | -6 | -10 | -17 | ||
| -5 | 1 | -6 | -4 | 10 | ||
| Net Cash Flow | 0 | -0 | 3 | 7 | -2 |
Ratios
Standalone Figures in Rs. Crores / View Consolidated
| Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
|---|---|---|---|---|---|---|
| Debtor Days | 53 | 62 | 25 | 39 | 53 | 96 |
| Inventory Days | 201 | 61 | 77 | 122 | 340 | 214 |
| Days Payable | 45 | 33 | 15 | 8 | 18 | 2 |
| Cash Conversion Cycle | 209 | 90 | 87 | 154 | 375 | 308 |
| Working Capital Days | 88 | 80 | 52 | 80 | 195 | 93 |
| ROCE % | 14% | 58% | 102% | 32% | 24% |
Documents
Announcements
-
Copy of Newspaper Publication
29 May 2025 - Shri Ahimsa Naturals published audited financial results for year ended March 31, 2025 in newspapers.
-
General Updates
28 May 2025 - Clarification: Financial results figures are in INR Lakhs, not absolute rupees.
-
General Updates
28 May 2025 - Investor presentation FY25: 23% revenue growth, IPO listing, ₹700L capex, net debt-free, FSSC 22000 approval.
-
Change in Directors/ Key Managerial Personnel/ Auditor/ Compliance Officer/ Share Transfer Agent
27 May 2025 - SHRI AHIMSA NATURALS LIMITED has informed about Change in Directors/ Key Managerial Personnel/ Auditor/ Compliance Officer/ Share Transfer Agent
-
Monitoring Agency Report
27 May 2025 - Quarterly monitoring report confirms Rs.35 Cr IPO proceeds unutilized, no deviations, compliance maintained.
Annual reports
No data available.
Concalls
-
May 2025TranscriptNotesPPT
Business Profile[1]
The Company is engaged in extracting and manufacturing Caffeine Anhydrous Natural, Green Coffee Bean Extracts (GCE), and Crude Caffeine, and trading in herbal extracts. It supplies food & beverages, nutraceuticals, cosmetics, and pharmaceutical industries.